BECAUSE EPTIFIBATIDE INHIBITS PLATELET AGGREGATION, CAUTION SHOULD BE EMPLOYED WHEN IT IS USED WITH OTHER DRUGS THAT AFFECT HEMOSTASIS, INCLUDING THROMBOLYTICS, ORAL ANTICOAGULANTS, NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, AND DIPYRIDAMOLE. TO AVOID POTENTIALLY ADDITIVE PHARMACOLOGIC EFFECTS, CONCOMITANT TREATMENT WITH OTHER INHIBITORS OF PLATELET RECEPTOR GP IIB/IIIA SHOULD BE AVOIDED.